Form EFFECT Checkpoint Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 4, 2025 |
| Accession Number: | 0001104659-25-054634 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Compass Nova Scotia Opens 13 New Co-op Homes Through Innovative Redevelopment
- QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
- WorldSkills Shanghai 2026 Opens with 1,385 Competitors from 68 Countries and Regions
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
